BridgeMD
New treatment option for In Vitro Fertilization
Official title Effect of Super-GDF9 on CAPA-IVM of COCs From Small Antral Follicles
ClinicalTrials.gov ID: NCT06766604
What this study is testing
- What it's testing
- CAPA-IVM (In Vitro Maturation) technology is an assisted reproductive method offering significant benefits in terms of safety and treatment costs, particularly for high-risk patients. These include individuals with ovarian hyperstimulation syndrome (OHSS), venous thrombosis, ovarian torsion, or polycystic ovary syndrome (PCOS).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 38, women only
You may be able to join if
- Women between the ages of 18 and 38 years (both inclusive)
- BMI ≤ 32 kg/m2
- PCOS women according to the Rotterdam criteria (2003)
- Indicating CAPA-IVM treatment.
- Serum AMH ≥ 4 ng/mL (28.57 pmol/L) at screening and having at least 24 antral follicles in two ovaries by transvaginal ultrasound at the time of...
You likely can't join if
- Known endometrioma or grade 3-4 endometriosis according to ASRM classification
- Uterine abnormalities
- Couples with severe male factor (sperm concentration \<5 million/ml, motility \< 10%), surgical sperm retrieval.
- Previous history of unexplained immature oocytes after IVF treatment
- Cycles using donor oocytes
See the full eligibility criteria
- Women between the ages of 18 and 38 years (both inclusive)
- BMI ≤ 32 kg/m2
- PCOS women according to the Rotterdam criteria (2003)
- Indicating CAPA-IVM treatment.
- Serum AMH ≥ 4 ng/mL (28.57 pmol/L) at screening and having at least 24 antral follicles in two ovaries by transvaginal ultrasound at the time of CAPA-IVM indication
- Willing to donate COCs for research purposes
- Agreeing for frozen embryo
- Signed informed consent before any study-related procedures
- Known endometrioma or grade 3-4 endometriosis according to ASRM classification
- Uterine abnormalities
- Couples with severe male factor (sperm concentration \<5 million/ml, motility \< 10%), surgical sperm retrieval.
- Previous history of unexplained immature oocytes after IVF treatment
- Cycles using donor oocytes
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.